Amylin Strikes First With Obesity Drug Deal: Biobuzz

Japanese drugmaker Takeda licenses worldwide rights to Amylin weight-loss pipeline.

Topics:  takeda   amylin   drug   
BING NEWS:
  • Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more
    Merck signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's oral obesity drug ...
    12/18/2024 - 1:23 am | View Link
  • Merck Joins Obesity Pill Race With $2B Hansoh Deal
    The Hansoh deal will let Merck compete in the crowded oral GLP-1 space alongside fellow pharma giants Eli Lilly, Novo Nordisk and Roche.
    12/18/2024 - 1:08 am | View Link
  • Merck signs deal worth up to $2 billion with China's Hansoh for oral obesity drug
    Merck on Wednesday signed a deal worth up to $2 billion with Hansoh Pharma to develop and sell the Chinese biotech's experimental oral obesity drug that works similar to the popular weight-loss ...
    12/18/2024 - 12:12 am | View Link
  • Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
    Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.
    12/17/2024 - 11:58 pm | View Link
  • Merck, Hansoh Pharma in Obesity Pill License Potentially Worth More Than $2 Billion
    Merck & Co. is licensing a potential oral obesity drug from Hansoh Pharma in a deal potentially worth more than $2 billion to the Chinese biopharmaceutical company.
    12/17/2024 - 11:24 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News